A case of methamphetamine use disorder treated with the antibiotic drug minocycline
- PMID: 20851278
- DOI: 10.1016/j.genhosppsych.2009.12.005
A case of methamphetamine use disorder treated with the antibiotic drug minocycline
Abstract
Methamphetamine (METH) use is one of the major public health concerns worldwide. Long-term use of METH induces not only dependence but also psychosis which is associated with METH-induced brain damage, including neuroinflammation produced by activated microglia. We report the case of a female patient whose psychotic symptoms in METH use disorder were successfully improved by anti-inflammatory drug minocycline therapy. Although the precise mechanism(s) underlying the efficacy of minocycline in METH use disorder are currently unclear, minocycline appears to be a good candidate for future investigation clinical trials for medication development in METH using populations.
Copyright © 2010 Elsevier Inc. All rights reserved.
Similar articles
-
Clinical features of sensitization to methamphetamine observed in patients with methamphetamine dependence and psychosis.Ann N Y Acad Sci. 2004 Oct;1025:279-87. doi: 10.1196/annals.1316.035. Ann N Y Acad Sci. 2004. PMID: 15542728 Review.
-
MDMA, methamphetamine and their combination: possible lessons for party drug users from recent preclinical research.Drug Alcohol Rev. 2007 Jan;26(1):9-15. doi: 10.1080/09595230601036945. Drug Alcohol Rev. 2007. PMID: 17364831 Review.
-
Protective effects of minocycline on behavioral changes and neurotoxicity in mice after administration of methamphetamine.Prog Neuropsychopharmacol Biol Psychiatry. 2006 Dec 30;30(8):1381-93. doi: 10.1016/j.pnpbp.2006.05.015. Epub 2006 Jul 12. Prog Neuropsychopharmacol Biol Psychiatry. 2006. PMID: 16839653
-
[Minocycline as a therapeutic drug for methamphetamine use disorders].Nihon Shinkei Seishin Yakurigaku Zasshi. 2008 Feb;28(1):19-22. Nihon Shinkei Seishin Yakurigaku Zasshi. 2008. PMID: 18411705 Review. Japanese.
-
Psychotic symptoms in methamphetamine psychotic in-patients.Int J Neuropsychopharmacol. 2003 Dec;6(4):347-52. doi: 10.1017/S1461145703003675. Int J Neuropsychopharmacol. 2003. PMID: 14604449
Cited by
-
SN79, a sigma receptor ligand, blocks methamphetamine-induced microglial activation and cytokine upregulation.Exp Neurol. 2013 Sep;247:134-42. doi: 10.1016/j.expneurol.2013.04.009. Epub 2013 Apr 28. Exp Neurol. 2013. PMID: 23631864 Free PMC article.
-
Toll-Like Receptor 4: A Novel Target to Tackle Drug Addiction?Handb Exp Pharmacol. 2022;276:275-290. doi: 10.1007/164_2022_586. Handb Exp Pharmacol. 2022. PMID: 35434747 Free PMC article.
-
Therapeutic targeting of neuroinflammation in methamphetamine use disorder.Future Med Chem. 2025 Jan;17(2):237-257. doi: 10.1080/17568919.2024.2447226. Epub 2024 Dec 27. Future Med Chem. 2025. PMID: 39727147 Review.
-
Minocycline reduces ethanol drinking.Brain Behav Immun. 2011 Jun;25 Suppl 1(Suppl 1):S165-9. doi: 10.1016/j.bbi.2011.03.002. Epub 2011 Mar 21. Brain Behav Immun. 2011. PMID: 21397005 Free PMC article.
-
MRI reveals differential effects of amphetamine exposure on neuroglia in vivo.FASEB J. 2013 Feb;27(2):712-24. doi: 10.1096/fj.12-220061. Epub 2012 Nov 12. FASEB J. 2013. PMID: 23150521 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical